In this study, the expression of TIM3 and its correlation with CD8+TILs exhaustion, the key ligand of TIM3, and the potential pathway of TIM3-mediated CD8+TILs in DLBCL were analyzed. Here, CD8A is linked to diffuse large B-cell lymphoma.